Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

Physio-Logic-InvestorsRegulatoryPerspective

96 vues

Publié le

  • Soyez le premier à commenter

  • Soyez le premier à aimer ceci

Physio-Logic-InvestorsRegulatoryPerspective

  1. 1. Quick Investors Reference Guide to Regulated Medical Device & Digital Health Space 1 Braingels 2016
  2. 2. This presentation is the sole property of Physio-logic Ltd and is protected by Copyright ©. Any use of this presentation without the prior written approval of Physio-Logic Ltd is prohibited. This presentation does not constitute regulatory advice and should not be regarded as replacing professional consultation. We recommend that you receive specific professional advice in relation to any regulatory matter.  What does regulation stands for?  How does it impact me?  Tips & pearls  Digital vs. non digital MD regulation in a nutshell 2
  3. 3.  Barrier to Market It Comes with the Territory…  Typically attributed to product approval by regulatory agencies (FDA, CE, AMAR etc.)  Extends to the entire lifecycle of medical device from inception to end of life  A collective name for three disciplines:  Regulatory Affairs (RA)  Quality Affairs (QA & QC)  Clinical Affairs (CA) What Does Regulation Stands for? 3
  4. 4.  Is my product regulated as Medical device?  What is its classification?  Which regulatory requirements apply to my product?  What is my time to market?  How much will it cost me?  Start up wisdom, innovation, leverage good regulatory science and medicine QRC Strategy & Work-plan What Does Regulation Stands for? 4
  5. 5. It Impacts Your ROI
  6. 6. The Impact –Early Stage How Does it Impact Me? 6  Betting on the “wrong horse”  Time to market  Do it right the first time:  Q: Are we developing the right product?  A: Due-dilligence; QA & CA feed the answer  Q: Are we developing the right product right?  A: Design control practice, Quality by design  Wrong doing, under doing, over doing  burn rate, dilution…diminsh ROI
  7. 7. Increase Your ROI How Does it Impact Me? 7  Valid Regulatory strategy  Clinical strategy  Quality plan  Gates  Control
  8. 8. Bottom Up QRC Work-plan & Budget How Does it Impact Me? 8  Harmonized with R&D WP  Manage your risk  Time to market  Burn rate  ROI
  9. 9. Compliance (Late Stage) How Does it Impact Me? 9
  10. 10. Tips & Pearls How Does it Impact Me? 10  Due diligence: screen strategy – is QRC project risk aligned with your investment strategy, are project plan and budget valid?  Control your investment – do it right the first time  Understand that ensuring your project is handled by competent QRC expert is in your best interest as investor
  11. 11.  Three risk classes  Risk vs. benefit  Intended use  General controls, special controls and PMA Medical Device Regulation 11 Digital Health Regulation  Four classes driven by risk and classification rules  Loosely tied to intended use  Conformity assessment Paradigm more established but struggling with innovation
  12. 12. Digital Health Regulation is Challenging • Regulation is (always) behind technology • Booming health apps. Nd Health IT products • Multiple stake holders (HIPPA, FD&C Act, FTC Act, CMS) • Multiple types (mHealth, CDS, Health IT, Personalized Medicine, Telemedicine, wearable device (IOT)) • The demarcation between FDA regulated product vs. nonregulated is complex and tricky at times. • The ramifications of this demarcation are extensive! 12
  13. 13.  Risk (privacy, hacking, injury, miss-diagnosis, delay of treatment, misuse, error)  Functionality focused (administrative, medical device etc.)  Narrowly tailored Risk Based Approach for Regulating Digital Health 13
  14. 14. Regulation Goes Beyond FDA  FCC, RTTE  FTC  HIPPA (Privacy, Security)  EC Privacy directive (95/46/EC)  ISO/IEC Health IT Standards  Liability for defective products (1985/374/EC &1999/34/EC)  General product safety (2001/95/EC)  Sale of consumer goods (1999/44/EC) and much more…..
  15. 15. Our Mission Statement Successfully Navigating the Regulatory Maze
  16. 16. Founded & Managed by Gadi Ginot • Over 20 years industry experience in managing Medical Device & Combination product regulation, quality and clinical development  Pharma (Teva)  Medical Device  International experience (scores of relocation to the EU, US) • Internationally renown • Unprecedented accomplishment in navigating precut certification thru FDA and Notified Body
  17. 17. Full Service Solution for Medical Device Manufacturer • Largest vendor in Israel (over 30 experts on board) • We cover all bases of Medical Device • Designated Digital Health Team  Usability  FDA 513(g), 510(k), PMA  CE Mark  ISO13485, ISO9001, CMDCAS  CLIA  International registration including AMAR, Russia, CFDA  Compliance  HW & SwQA  Design Control  Risk Management  Performance evaluation  Clinical evaluation  Clinical Trials  HIPPA  Cybersecurity
  18. 18. Gadi Ginot: gadi@physio-logic.co.il 050-8317449 www.physio-logic.co.il 18

×